Hookipa Biotech Gmbh
Clinical trials sponsored by Hookipa Biotech Gmbh, explained in plain language.
-
Experimental HIV therapy aims to train body to fight virus
Disease control TerminatedThis study tested two experimental treatments, HB-502 and HB-501, designed to teach the immune system to recognize and attack HIV. It involved 30 adults with HIV who were already on stable antiretroviral therapy (ART). The goal was to check if the treatments are safe and can trig…
Phase: PHASE1 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated May 19, 2026 12:01 UTC
-
Experimental cancer drug tested in tiny early trial
Knowledge-focused TerminatedThis early-phase trial tested an experimental drug called HB-201 in 10 people with HPV 16-positive head and neck or cervical cancer. The goal was to see how the drug affects the immune system's response to the cancer. The study was terminated early, so results are limited.
Phase: EARLY_PHASE1 • Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC